Hexiris Pharma Welcomes World-Renowned Ophthalmologist Dr. Ike Ahmed to its Scientific Committee
October 30, 2023 07:30 ET
|
Hexiris Inc.
DIEPPE, New Brunswick, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Hexiris Pharma Inc. (“Hexiris Pharma” or the “Company”), a pharmaceutical firm dedicated to advancing and simplifying Minimally Invasive...
EyePoint Pharmaceuticals Announces Presentations at Eyecelerator 2023, American Academy of Ophthalmology Annual Meeting 2023 and Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference 2023
October 30, 2023 07:00 ET
|
EyePoint Pharmaceuticals, Inc.
WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the...
Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference
October 30, 2023 05:30 ET
|
Opthea Limited
MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and...
The Myopia Management Center of Excellence is Accepting New Patients
October 27, 2023 16:45 ET
|
Medical Optometry America - Myopia Management Center of Excellence
Newtown Township, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Newtown Township, Pennsylvania - The Myopia Management Center of Excellence is currently accepting new myopia patients. Located at 3475 West...
Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting
October 27, 2023 08:00 ET
|
Belite Bio, Inc
Two-year data from the two-year Phase 1b/2 trial of Tinlarebant (LBS-008) in adolescent Stargardt Disease (STGD1) to be presentedA two-year global Phase 3 trial in adolescent STGD1 (the “DRAGON”...
Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
October 27, 2023 05:30 ET
|
Opthea Limited
Dr. Megan Baldwin transitions to Founder, Chief Innovation Officer and remains on the Board of Directors Experienced pharmaceutical executives Dr. Frederic Guerard appointed as CEO and Peter...
Iridex to Report Third Quarter Financial Results on November 14, 2023
October 26, 2023 16:22 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
LUMIBIRD: REVENUES FOR THE FIRST 9 MONTHS OF 2023: €139.0M (+11%)
October 24, 2023 11:45 ET
|
Lumibird SA
Lannion, October 24, 2023 – 5:45pm REVENUES FOR THE FIRST 9 MONTHS OF 2023: €139.0M (+11%) Continued growth for both divisions at constant exchange ratesStrong level of activity expected in Q4 The...
Prime Medicine Presents First In Vivo Proof-of-Concept Prime Editing Data Demonstrating Ability of Prime Editors to Treat Ophthalmological Diseases
October 24, 2023 07:30 ET
|
Prime Medicine, Inc.
Prime Medicine Presents First In Vivo Proof-of-Concept Prime Editing Data Demonstrating Ability of Prime Editors to Treat Ophthalmological Diseases
Sight Sciences to Host SAHARA 6 Month RCT Results Reception at the American Academy of Ophthalmology 2023
October 19, 2023 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and...